Expression of Extracellular SOD and iNOS in Macrophages and Smooth Muscle Cells in Human and Rabbit Atherosclerotic Lesions

Colocalization With Epitopes Characteristic of Oxidized LDL and Peroxynitrite-Modified Proteins

From the A.I. Virtanen Institute and Department of Medicine, University of Kuopio, Kuopio, Finland (J.S.L., S.Y.-H.); the Department of Clinical Chemistry, Umeå University Hospital, Umeå, Sweden (P.S., S.L.M.); the Department of Medical Biochemistry, Medical School, University of Tampere, Tampere, Finland (T.P.H.); and the Department of Forensic Medicine, University of Oulu, Oulu, Finland (T.S.).

Correspondence to Seppo Ylä-Herttuala, MD, PhD, A.I. Virtanen Institute, Molecular Medicine, University of Kuopio, Neulaniementie 2, PO Box 1627, FIN-70211 Kuopio, Finland. E-mail ylahertt{at}keula.uku.fi

Abstract—Oxidative processes play an important role in atherogenesis. Because superoxide anion and nitric oxide (NO) are important mediators in vascular pathology, we studied the expression of extracellular superoxide dismutase (EC-SOD) and inducible nitric oxide synthase (iNOS) in human and rabbit atherosclerotic lesions by using simultaneous in situ hybridization and immunocytochemistry and EC-SOD enzyme activity measurements. We also analyzed the presence in the arterial wall of oxidized lipoproteins and peroxynitrite-modified proteins as indicators of oxidative damage and possible mediators in vascular pathology. EC-SOD and iNOS mRNA and protein were expressed in smooth muscle cells and macrophages in early and advanced lesions. The expression of both enzymes was especially prominent in macrophages. As measured by enzyme activity, EC-SOD was the major SOD isoenzyme in the arterial wall. EC-SOD activity was higher in highly cellular rabbit lesions but lower in advanced, connective tissue–rich human lesions. Despite the abundant expression of EC-SOD, malondialdehyde-lysine and hydroxynonenal-lysine epitopes characteristic of oxidized lipoproteins and nitrotyrosine residues characteristic of peroxynitrite-modified proteins were detected in iNOS-positive, macrophage-rich lesions, thus implying that malondialdehyde, hydroxynonenal, and peroxynitrite are important mediators of oxidative damage. We conclude that EC-SOD, iNOS, and the balance between NO and superoxide anion play important roles in atherogenesis. EC-SOD and iNOS are highly expressed in lesion macrophages. High EC-SOD expression in the arterial wall may be required not only to prevent deleterious effects of superoxide anion but also to preserve NO activity and prevent peroxynitrite formation. Modulation of arterial EC-SOD and iNOS activities could provide means to protect arteries against atherosclerotic vascular disease.

Key Words: SOD • inducible nitric oxide synthase • macrophages • oxidized LDL • peroxynitrite

This article has been cited by other articles:

				A.-L. Levonen, E. Vahakangas, J. K. Koponen, and S. Yla-Herttuala Antioxidant Gene Therapy for Cardiovascular Disease: Current Status and Future Perspectives Circulation, April 22, 2008; 117(16): 2142 - 2150. [Abstract] [Full Text] [PDF]

				X.-m. Liu, K. J. Peyton, D. Ensenat, H. Wang, M. Hannink, J. Alam, and W. Durante Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival Cardiovasc Res, July 15, 2007; 75(2): 381 - 389. [Abstract] [Full Text] [PDF]

				A. C. Thomas, G. B. Sala-Newby, Y. Ismail, J. L. Johnson, G. Pasterkamp, and A. C. Newby Genomics of Foam Cells and Nonfoamy Macrophages From Rabbits Identifies Arginase-I as a Differential Regulator of Nitric Oxide Production Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 571 - 577. [Abstract] [Full Text] [PDF]

				P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]

				M. Ohashi, M. S. Runge, F. M. Faraci, and D. D. Heistad MnSOD Deficiency Increases Endothelial Dysfunction in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2331 - 2336. [Abstract] [Full Text] [PDF]

				R. S. Deeb, H. Shen, C. Gamss, T. Gavrilova, B. D. Summers, R. Kraemer, G. Hao, S. S. Gross, M. Laine, N. Maeda, et al. Inducible Nitric Oxide Synthase Mediates Prostaglandin H2 Synthase Nitration and Suppresses Eicosanoid Production Am. J. Pathol., January 1, 2006; 168(1): 349 - 362. [Abstract] [Full Text] [PDF]

				I. Qureshi, H. Chen, A. T Brown, R. Fitzgerald, X. Zhang, J. Breckenridge, R. Kazi, A. J Crocker, M. C Stuhlingexsr, K. Lin, et al. Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor Vascular Medicine, August 1, 2005; 10(3): 215 - 223. [Abstract] [PDF]

				J. S. Ikonomidis, J. W. Hendrick, A. M. Parkhurst, A. R. Herron, P. G. Escobar, K. B. Dowdy, R. E. Stroud, E. Hapke, M. R. Zile, and F. G. Spinale Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H149 - H158. [Abstract] [Full Text] [PDF]

				A. D. Nguyen, S. Itoh, V. Jeney, H. Yanagisawa, M. Fujimoto, M. Ushio-Fukai, and T. Fukai Fibulin-5 Is a Novel Binding Protein for Extracellular Superoxide Dismutase Circ. Res., November 26, 2004; 95(11): 1067 - 1074. [Abstract] [Full Text] [PDF]

				V. O. Melichar, D. Behr-Roussel, U. Zabel, L. O. Uttenthal, J. Rodrigo, A. Rupin, T. J. Verbeuren, A. Kumar H. S., and H. H. H. W. Schmidt Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis PNAS, November 23, 2004; 101(47): 16671 - 16676. [Abstract] [Full Text] [PDF]

				R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]

				K. Juul, A. Tybjaerg-Hansen, S. Marklund, N. H.H. Heegaard, R. Steffensen, H. Sillesen, G. Jensen, and B. G. Nordestgaard Genetically Reduced Antioxidative Protection and Increased Ischemic Heart Disease Risk: The Copenhagen City Heart Study Circulation, January 6, 2004; 109(1): 59 - 65. [Abstract] [Full Text] [PDF]

				M. Horiuchi, M. Tsutsui, H. Tasaki, T. Morishita, O. Suda, S. Nakata, S.-i. Nihei, M. Miyamoto, R. Kouzuma, M. Okazaki, et al. Upregulation of Vascular Extracellular Superoxide Dismutase in Patients With Acute Coronary Syndromes Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 106 - 111. [Abstract] [Full Text] [PDF]

				T. T. Tuomisto, A. Korkeela, J. Rutanen, H. Viita, J. H. Brasen, M. S. Riekkinen, T. T. Rissanen, K. Karkola, Z. Kiraly, K. Kolble, et al. Gene Expression in Macrophage-Rich Inflammatory Cell Infiltrates in Human Atherosclerotic Lesions as Studied by Laser Microdissection and DNA Array: Overexpression of HMG-CoA Reductase, Colony Stimulating Factor Receptors, CD11A/CD18 Integrins, and Interleukin Receptors Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2235 - 2240. [Abstract] [Full Text] [PDF]

				C.-L. M Cooke and S. T Davidge Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice Cardiovasc Res, December 1, 2003; 60(3): 635 - 642. [Abstract] [Full Text] [PDF]

				A. Pierce, J. Whitlark, and L. Dory Extracellular Superoxide Dismutase Polymorphism in Mice Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1820 - 1825. [Abstract] [Full Text] [PDF]

				H. KOSAKA, H. YONEYAMA, L. ZHANG, S. FUJII, A. YAMAMOTO, and J. IGARASHI Induction of LOX-1 and iNOS expressions by ischemia-reperfusion of rat kidney and the opposing effect of L-arginine FASEB J, April 1, 2003; 17(6): 636 - 643. [Abstract] [Full Text] [PDF]

				I. V. Turko and F. Murad Protein Nitration in Cardiovascular Diseases Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634. [Abstract] [Full Text] [PDF]

				M. O. Laukkanen, A. Kivela, T. Rissanen, J. Rutanen, M. K. Karkkainen, O. Leppanen, J. H. Brasen, and S. Yla-Herttuala Adenovirus-Mediated Extracellular Superoxide Dismutase Gene Therapy Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta Circulation, October 8, 2002; 106(15): 1999 - 2003. [Abstract] [Full Text] [PDF]

				U. Landmesser and H. Drexler Toward Understanding of Extracellular Superoxide Dismutase Regulation in Atherosclerosis: A Novel Role of Uric Acid? Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1367 - 1368. [Full Text] [PDF]

				H. U. Hink, N. Santanam, S. Dikalov, L. McCann, A. D. Nguyen, S. Parthasarathy, D. G. Harrison, and T. Fukai Peroxidase Properties of Extracellular Superoxide Dismutase: Role of Uric Acid in Modulating In Vivo Activity Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1402 - 1408. [Abstract] [Full Text] [PDF]

				T. Fukai, R. J Folz, U. Landmesser, and D. G Harrison Extracellular superoxide dismutase and cardiovascular disease Cardiovasc Res, August 1, 2002; 55(2): 239 - 249. [Abstract] [Full Text] [PDF]

				T. Adachi, R. Matsui, S. Xu, M. Kirber, H. L. Lazar, V. S. Sharov, C. Schoneich, and R. A. Cohen Antioxidant Improves Smooth Muscle Sarco/Endoplasmic Reticulum Ca2+-ATPase Function and Lowers Tyrosine Nitration in Hypercholesterolemia and Improves Nitric Oxide-Induced Relaxation Circ. Res., May 31, 2002; 90(10): 1114 - 1121. [Abstract] [Full Text] [PDF]

				H.U. HINK and T. FUKAI Extracellular Superoxide Dismutase, Uric Acid, and Atherosclerosis Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 483 - 490. [Abstract] [PDF]

				P. Stralin and S. L. Marklund Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1621 - H1629. [Abstract] [Full Text] [PDF]

				A. Behndig, K. Karlsson, B. O. Johansson, T. Brannstrom, and S. L. Marklund Superoxide Dismutase Isoenzymes in the Normal and Diseased Human Cornea Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2293 - 2296. [Abstract] [Full Text] [PDF]

				J. Nilsson Absence of EC-SOD Does Not Promote Atherogenesis in Mice: Have We Lost Yet Another Player? Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1387 - 1388. [Full Text] [PDF]

				M.-L. Sentman, T. Brannstrom, S. Westerlund, M. O. Laukkanen, S. Yla-Herttuala, S. Basu, and S. L. Marklund Extracellular Superoxide Dismutase Deficiency and Atherosclerosis in Mice Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1477 - 1482. [Abstract] [Full Text] [PDF]

				W. Li, H. Dalen, J. W. Eaton, and X.-M. Yuan Apoptotic Death of Inflammatory Cells in Human Atheroma Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1124 - 1130. [Abstract] [Full Text] [PDF]

				S. Sasu, A. L. Cooper, and D. Beasley Juxtacrine effects of IL-1{alpha} precursor promote iNOS expression in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1615 - H1623. [Abstract] [Full Text] [PDF]

				X.-L. Niu, X. Yang, K. Hoshiai, K. Tanaka, S. Sawamura, Y. Koga, and H. Nakazawa Inducible Nitric Oxide Synthase Deficiency Does Not Affect the Susceptibility of Mice to Atherosclerosis but Increases Collagen Content in Lesions Circulation, February 27, 2001; 103(8): 1115 - 1120. [Abstract] [Full Text] [PDF]

				K. Öörni, M. O. Pentikäinen, M. Ala-Korpela, and P. T. Kovanen Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions J. Lipid Res., November 1, 2000; 41(11): 1703 - 1714. [Abstract] [Full Text]

				P. A. Detmers, M. Hernandez, J. Mudgett, H. Hassing, C. Burton, S. Mundt, S. Chun, D. Fletcher, D. J. Card, J. Lisnock, et al. Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice J. Immunol., September 15, 2000; 165(6): 3430 - 3435. [Abstract] [Full Text] [PDF]

				B. Halliwell Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc Res, August 18, 2000; 47(3): 410 - 418. [Full Text] [PDF]

				G. R. Y. De Meyer, M. M. Kockx, K. M. Cromheeke, C. I. Seye, A. G. Herman, and H. Bult Periadventitial Inducible Nitric Oxide Synthase Expression and Intimal Thickening Arterioscler Thromb Vasc Biol, August 1, 2000; 20(8): 1896 - 1902. [Abstract] [Full Text] [PDF]

				A. C. Carr, M. R. McCall, and B. Frei Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species : Reaction Pathways and Antioxidant Protection Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1716 - 1723. [Abstract] [Full Text] [PDF]

				U. Landmesser, R. Merten, S. Spiekermann, K. Buttner, H. Drexler, and B. Hornig Vascular Extracellular Superoxide Dismutase Activity in Patients With Coronary Artery Disease : Relation to Endothelium-Dependent Vasodilation Circulation, May 16, 2000; 101(19): 2264 - 2270. [Abstract] [Full Text] [PDF]

				B. Jiang and P. Brecher N-Acetyl-L-Cysteine Potentiates Interleukin-1{beta} Induction of Nitric Oxide Synthase : Role of p44/42 Mitogen-Activated Protein Kinases Hypertension, April 1, 2000; 35(4): 914 - 918. [Abstract] [Full Text] [PDF]

				M. C. Mahaney, S. A. Czerwinski, T. Adachi, D. E. L. Wilcken, and X. L. Wang Plasma Levels of Extracellular Superoxide Dismutase in an Australian Population : Genetic Contribution to Normal Variation and Correlations With Plasma Nitric Oxide and Apolipoprotein A-I Levels Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 683 - 688. [Abstract] [Full Text] [PDF]

				M. M Kockx and A. G Herman Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res, February 1, 2000; 45(3): 736 - 746. [Abstract] [Full Text] [PDF]

				S. Dieterich, U. Bieligk, K. Beulich, G. Hasenfuss, and J. Prestle Gene Expression of Antioxidative Enzymes in the Human Heart : Increased Expression of Catalase in the End-Stage Failing Heart Circulation, January 4, 2000; 101(1): 33 - 39. [Abstract] [Full Text] [PDF]

				K.-Y. Chyu, P. Dimayuga, J. Zhu, J. Nilsson, S. Kaul, P. K. Shah, and B. Cercek Decreased Neointimal Thickening After Arterial Wall Injury in Inducible Nitric Oxide Synthase Knockout Mice Circ. Res., December 3, 1999; 85(12): 1192 - 1198. [Abstract] [Full Text] [PDF]

				T. Hakkinen, J. S. Luoma, M. O. Hiltunen, C. H. Macphee, K. J. Milliner, L. Patel, S. Q. Rice, D. G. Tew, K. Karkola, and S. Yla-Herttuala Lipoprotein-Associated Phospholipase A2, Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 2909 - 2917. [Abstract] [Full Text] [PDF]

				A. Ishida, T. Sasaguri, Y. Miwa, C. Kosaka, Y. Taba, and T. Abumiya Tumor Suppressor p53 But Not cGMP Mediates NO-Induced Expression of p21Waf1/Cip1/Sdi1 in Vascular Smooth Muscle Cells Mol. Pharmacol., November 1, 1999; 56(5): 938 - 946. [Abstract] [Full Text]

				B. Jiang, M. Haverty, and P. Brecher N-Acetyl-L-Cysteine Enhances Interleukin-1{beta}-Induced Nitric Oxide Synthase Expression Hypertension, October 1, 1999; 34(4): 574 - 579. [Abstract] [Full Text] [PDF]

				M. O. Laukkanen, S. Mannermaa, M. O. Hiltunen, S. Aittomaki, K. Airenne, J. Janne, and S. Yla-Herttuala Local Hypomethylation in Atherosclerosis Found in Rabbit ec-sod Gene Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2171 - 2178. [Abstract] [Full Text] [PDF]

				J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF]

				M. Kibbe, T. Billiar, and E. Tzeng Inducible nitric oxide synthase and vascular injury Cardiovasc Res, August 15, 1999; 43(3): 650 - 657. [Abstract] [Full Text] [PDF]

				K. M Cromheeke, M. M Kockx, G. R.Y De Meyer, J. M Bosmans, H. Bult, W. J.F Beelaerts, C. J Vrints, and A. G Herman Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques Cardiovasc Res, August 15, 1999; 43(3): 744 - 754. [Abstract] [Full Text] [PDF]

				C. A. E. MASON, P. CHANG, C. FALLERY, and M. RABINOVITCH Nitric oxide mediates LC-3-dependent regulation of fibronectin in ductus arteriosus intimal cushion formation FASEB J, August 1, 1999; 13(11): 1423 - 1434. [Abstract] [Full Text]

				Z. Mallat, C. Heymes, J. Ohan, E. Faggin, G. Leseche, and A. Tedgui Expression of Interleukin-10 in Advanced Human Atherosclerotic Plaques : Relation to Inducible Nitric Oxide Synthase Expression and Cell Death Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 611 - 616. [Abstract] [Full Text] [PDF]

				R. C.M. Siow, H. Sato, and G. E. Mann Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res, February 1, 1999; 41(2): 385 - 394. [Abstract] [Full Text] [PDF]

				C. Depre, X. Havaux, J. Renkin, J. L. J. Vanoverschelde, and W. Wijns Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque Cardiovasc Res, February 1, 1999; 41(2): 465 - 472. [Abstract] [Full Text] [PDF]

				Y. Yanagitani, H. Rakugi, A. Okamura, K. Moriguchi, S. Takiuchi, M. Ohishi, K. Suzuki, J. Higaki, and T. Ogihara Angiotensin II Type 1 Receptor–Mediated Peroxide Production in Human Macrophages Hypertension, January 1, 1999; 33(1): 335 - 339. [Abstract] [Full Text] [PDF]

				X. L. Wang, T. Adachi, A. S. Sim, and D. E. L. Wilcken Plasma Extracellular Superoxide Dismutase Levels in an Australian Population With Coronary Artery Disease Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1915 - 1921. [Abstract] [Full Text] [PDF]

				A. C. Carr and B. Frei The Nitric Oxide Congener Nitrite Inhibits Myeloperoxidase/H2O2/ Cl--mediated Modification of Low Density Lipoprotein J. Biol. Chem., January 12, 2001; 276(3): 1822 - 1828. [Abstract] [Full Text] [PDF]

				C. A. E. O'Blenes, C. Kinnear, and M. Rabinovitch Tumor Necrosis Factor-{alpha} Induces Fibronectin Synthesis in Coronary Artery Smooth Muscle Cells by a Nitric Oxide-Dependent Posttranscriptional Mechanism Circ. Res., July 6, 2001; 89(1): 26 - 32. [Abstract] [Full Text] [PDF]